Valuation
Is the price right?2/2 inputs reported · High confidence
Stronger than most peers on:
- ▲ Earnings yield
- ▲ P/B
Behind the score
Earnings yield (P/E) and book yield (P/B) versus other banks and insurers.
Bringing the fundamentals into focus…
Price as of close on Nov 3, 2026 · Financials updated Nov 2, 2026
2/2 inputs reported · High confidence
Stronger than most peers on:
Earnings yield (P/E) and book yield (P/B) versus other banks and insurers.
1/1 inputs reported · High confidence
Stronger than most peers on:
Earnings-per-share growth versus other banks and insurers.
2/2 inputs reported · High confidence
Why it changed since the Oct 27, 2026 close: Score 43 → 42
Close to the peer norm on every measure.
Return on equity and return on assets versus other banks and insurers.
Not rated for banks and insurers: debt and share-price swings say little about their risk. We leave it blank rather than fill the gap with a made-up middle value.
Valuation, growth and profitability scores: higher is better. Risk: 0 is lower, 2 is higher. Risk is a relative proxy, not a bankruptcy probability. Scores depend on available sector peers.
No major changes
| Previous quarter | Latest quarter | Change | |
|---|---|---|---|
| Net income (12 months) | 53.9M USD | 56.3M USD | +4.6% |
| Free cash flow (12 months) | 29.5M USD | 36.5M USD | +23.4% |
| Cash | 222.2M USD | 169.8M USD | −23.6% |
| Shares outstanding | 27.9M | 27.9M | +0.0% |
From the company’s own SEC filings, as filed. Twelve-month figures roll forward one quarter at a time.
Valuations in Banks - Regional are within their usual range since 2016.
| Key ratios | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | Change |
|---|---|---|---|---|---|---|
| Return on assets (ROA) | 1.3% | 1.2% | 0.9% | 0.6% | 0.9% | ▲ 0.2 pts |
| Return on equity (ROE) | 12.0% | 13.5% | 9.4% | 7.2% | 8.9% | ▲ 1.7 pts |
| Debt to equity | — | 0.03× | 0.03× | 0.03× | — | — |
Price history is added with the daily price update and will appear after the next one.